(Q40396673)

20 September 2017

1 reference

title

Insulin-like growth factors: clinical experience in ovarian function (English)

1 reference

20 September 2017

R P Buyalos

1

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

American Journal of Medicine

20 September 2017

published in

1 reference

20 September 2017

volume

98

1 reference

20 September 2017

issue

1A

1 reference

20 September 2017

page(s)

55S-66S

1 reference

Insulin-like growth factors and their binding proteins

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Primary structure of human insulin-like growth factor II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin-like growth factor receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Structure, Evolution, Expression and Regulation of Insulin-Like Growth Factors I and II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Growth hormone dependence of somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II messenger ribonucleic acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Estrogen induces insulin-like growth factor-I expression in the rat uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Binding proteins for the insulin-like growth factors: structure, regulation and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Somatomedin (insulin-like growth factors)-binding proteins. Molecular forms and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 1. Circulating forms in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Anatomy of the Human Ovarian Insulin-Like Growth Factor System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin-like growth factor II in follicular fluid of the patients with in vitro fertilization and embryo transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Cotreatment with human growth hormone and gonadotropins for induction of ovulation: a controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

A comparison of follicular fluid levels of insulin-like growth factor-1 in normal dominant and cohort follicles, polycystic and multicystic ovaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Follicular fluid concentrations of insulin-like growth factor 1, epidermal growth factor, transforming growth factor-alpha and sex-steroids in volume matched normal and polycystic human follicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Identification of Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) and IGFBP-2 in Human Follicular Fluid*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin-like growth factors and their binding proteins in human follicular fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Immunoreactive insulin-like growth factor I in human follicular fluid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Identification of insulin-like growth factor-II in human seminal and follicular fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Supplementary growth hormone treatment of women with poor ovarian response to exogenous gonadotrophins: changes in serum and follicular fluid insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Growth hormone facilitates ovulation induction by gonadotrophins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin and insulin-like growth factor I in follicular fluid after induction of ovulation in women undergoing in vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Human antral fluid IGF-I and oocyte maturity: effect of stimulation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Expression of insulin-like growth factor-II (IGF-II) messenger ribonucleic acid (mRNA), but not IGF-I mRNA, in human preovulatory granulosa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin-like growth factor I (IGF-I), IGF-I receptors, and IGF binding proteins 1-4 in human uterine tissue: tissue localization and IGF-I action in endometrial stromal and myometrial smooth muscle cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin-like growth factor I gene expression in the rat ovary is confined to the granulosa cells of developing follicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Cellular Pattern of Insulin-Like Growth Factor-I (IGF-I) and IGF-I Receptor Gene Expression in the Developing and Mature Ovarian Follicle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin-like growth factor-I (IGF-I) and IGF-II hormonal action in cultured rat granulosa cells: mediation via type I but not type II IGF receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

The polycystic ovary. I. Clinical and histologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin resistance in nonobese patients with polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: A common endocrinopathy with distinct pathophysiologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Distribution and characterization of insulin and insulin-like growth factor I receptors in normal human ovary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (type A insulin resistance).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin and insulin-like growth factor-I responsiveness in polycystic ovarian syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Plasma levels of insulin-like growth factor-I and its binding protein in polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Structural and immunological comparison of insulin-like growth factor binding proteins of cerebrospinal and amniotic fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Radioimmunoassay of placental protein 12: Levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women, and patients with trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Monoclonal antibodies to the 27-34K insulin-like growth factor binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Human preovulatory follicular fluid, luteinized cells of hyperstimulated preovulatory follicles, and corpus luteum contain placental protein 12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

The somatomedin C binding protein: evidence for a heterologous subunit structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Levels of the small insulin-like growth factor-binding protein are strongly related to those of insulin in prepubertal and pubertal children but only weakly so after puberty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Regulation of the growth hormone-independent growth factor-binding protein in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Regulation of insulin-like growth factor-binding protein-1 production in human granulosa-luteal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin-like growth factor binding protein-1 in female reproductive functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Short and Long Term Effects of Growth Hormone on Circulating Levels of Insulin-Like Growth Factor-I (IGF-I), IGF-Binding Protein-1, and Insulin: A Placebo Controlled Study*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin-like growth factor binding proteins in follicular fluid from normal dominant and cohort follicles, polycystic and multicystic ovaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

An insulin-like growth factor-binding protein in ovarian follicular fluid blocks follicle-stimulating hormone-stimulated steroid production by ovarian granulosa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin-like growth factor-binding protein (IGF-BP) inhibition of granulosa cell function: effect on cyclic adenosine 3',5'-monophosphate, deoxyribonucleic acid synthesis, and comparison with the effect of an IGF-I antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

The effect of weight loss on sex steroid secretion and binding in massively obese women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Ovarian response to combined growth hormone-gonadotropin treatment in patients resistant to induction of superovulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Co-treatment with growth hormone of sub-optimal responders in IVF-ET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Immunohistochemical localization of growth hormone-releasing hormone in human gonads

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Cellular localization of the growth hormone receptor/binding protein in the male and female reproductive systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Effect of superovulation with human menopausal gonadotropins on growth hormone levels in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Delay of puberty onset in females due to suppression of growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

The potentiating effect of growth hormone on follicle stimulation with human menopausal gonadotropin in a panhypopituitary patient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Clinical use of growth hormone-releasing factor for induction of superovulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Growth hormone secretory capacity and serum insulin-like growth factor I levels in primary infertile, anovulatory women with regular menses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Mechanism and management of ovulatory failure in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Serum levels of insulin-like growth factor binding protein-1 and ovulatory responses to clomiphene citrate in women with polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Insulin-like growth factor-II stimulates human granulosa-luteal cell proliferation in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

Effect of insulin-like growth factor I on steroidogenesis in cultured human granulosa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

7 January 2021

Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

7 January 2021

Insulin-like growth factor I (IGF-I) levels in follicular fluid from human preovulatory follicles: correlation with serum IGF-I levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

7 January 2021

The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

7 January 2021

Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

7 January 2021

Growth hormone in serum of women during the menstrual cycle and during controlled ovarian hyperstimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

7 January 2021

Can growth hormone increase, after clonidine administration, predict the dose of human menopausal hormone needed for induction of ovulation?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980060-6

7 January 2021

10.1016/S0002-9343(99)80060-6

Identifiers

DOI

1 reference

20 September 2017

1 reference